BrightHeart
Healthcare Software · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7-11 Bd Haussmann, Paris, Ile-de-France,...Website
www.brightheart.aiRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About BrightHeart
Led by CEO Cécile Dupont, BrightHeart is a provider of artificial intelligence (AI) solutions for prenatal ultrasound, with an AI software platform that delivers support across the entire ultrasound exam, providing guidance at every step for fetal heart screening, precise tracking of the evaluations. Its FDA-cleared medical devices integrate directly into routine ultrasound workflows to deliver fetal heart screening, improve exam completeness, save time, and support confident clinical decision-making.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BrightHeart your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BrightHeart is spiking on competitors!
Funding: Get notified immidiatlly once BrightHeart has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at BrightHeart
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BrightHeart had a recent Job posting/layoffs
Product Launch: Get notified when BrightHeart launches new products
Check if BrightHeart has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BrightHeart recently announced quarterly report
BrightHeart, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
BrightHeart is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
BrightHeart is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about BrightHeart.
BrightHeart financials insights
Gather financial insights about BrightHeart, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$2.1M
2026
Series A
$12.8M
BrightHeart Tech Stack
A closer look at the technologies used by BrightHeart
See more technologies
Most Recent Scoops
Funding
Funding
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Board of Directors
Funding
BrightHeart News & Media
BrightHeart Raises €11M Series A for AI-Powered Prenatal Ultrasound Platform
BrightHeart, a Paris-based company developing AI for prenatal ultrasound, has raised €11 million in Series A funding. The round was co-led by Odyssée Venture and GO Capital, with participation from the Mussallem CHD Alliance, Lift Value, IDAHO HealthTech Club via Side Angels, and founding investor Sofinnova Partners. Angel investors in the round include Professor LaurentFDA Clears AI Tool to Assist with Fetal Heart Ultrasound Scans
The tool automatically detects the standard views required for second- and third-trimester fetal heart ultrasound evaluations.BrightHeart Obtains Third FDA Clearance and PCCP Approval, Becoming First to Offer One Integrated Solution for Real-Time Fetal Heart Documentation and CHD Detection
PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its second device, B-Right Views. This AI powered tool automatically detects the standard views required for second and third-trimester fetal heart ultrasound evaluations within routine anatomy scans. The software supports fetal heart exams by confirming when aBrightHeart Obtains Second FDA Clearance for Expansion of Platform Capabilities - Adding Tablet Support For Fetal Heart Ultrasound Evaluations
PARIS--(BUSINESS WIRE)--BrightHeart, a global leader in artificial intelligence (AI) solutions for obstetrics and pediatric cardiology, announced today the 510(k) clearance for updates to the BrightHeart platform, adds the capability for clinicians to access the BrightHeart analysis in real-time through a cart-side tablet. BrightHeart’s innovative AI technology addresses a critical unmet clinical need, targeting the significant challenge of screening for congenital heart defects (CHDs), the mos
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BrightHeart
Sign Up For FreeTo access detailed company insights
Led by CEO Cécile Dupont, BrightHeart is a provider of artificial intelligence (AI) solutions for prenatal ultrasound, with an AI software platform that delivers support across the entire ultrasound exam, providing guidance at every step for fetal heart screening, precise tracking of the evaluations. Its FDA-cleared medical devices integrate direct... Read More
